382 related articles for article (PubMed ID: 18398673)
1. Amphiregulin: role in mammary gland development and breast cancer.
McBryan J; Howlin J; Napoletano S; Martin F
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):159-69. PubMed ID: 18398673
[TBL] [Abstract][Full Text] [Related]
2. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development.
Ciarloni L; Mallepell S; Brisken C
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5455-60. PubMed ID: 17369357
[TBL] [Abstract][Full Text] [Related]
3. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.
Sternlicht MD; Sunnarborg SW
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):181-94. PubMed ID: 18470483
[TBL] [Abstract][Full Text] [Related]
4. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.
Sternlicht MD; Sunnarborg SW; Kouros-Mehr H; Yu Y; Lee DC; Werb Z
Development; 2005 Sep; 132(17):3923-33. PubMed ID: 16079154
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 determines estrogen signaling in the mammary gland in vivo.
Casimiro MC; Wang C; Li Z; Di Sante G; Willmart NE; Addya S; Chen L; Liu Y; Lisanti MP; Pestell RG
Mol Endocrinol; 2013 Sep; 27(9):1415-28. PubMed ID: 23864650
[TBL] [Abstract][Full Text] [Related]
6. Ectodysplasin regulates hormone-independent mammary ductal morphogenesis via NF-κB.
Voutilainen M; Lindfors PH; Lefebvre S; Ahtiainen L; Fliniaux I; Rysti E; Murtoniemi M; Schneider P; Schmidt-Ullrich R; Mikkola ML
Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5744-9. PubMed ID: 22451941
[TBL] [Abstract][Full Text] [Related]
7. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development.
Luetteke NC; Qiu TH; Fenton SE; Troyer KL; Riedel RF; Chang A; Lee DC
Development; 1999 Jun; 126(12):2739-50. PubMed ID: 10331984
[TBL] [Abstract][Full Text] [Related]
8. Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers.
Kariagina A; Xie J; Leipprandt JR; Haslam SZ
Horm Cancer; 2010 Oct; 1(5):229-44. PubMed ID: 21258428
[TBL] [Abstract][Full Text] [Related]
9. ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis.
McBryan J; Howlin J; Kenny PA; Shioda T; Martin F
Oncogene; 2007 Sep; 26(44):6406-19. PubMed ID: 17486082
[TBL] [Abstract][Full Text] [Related]
10. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.
Bade LK; Goldberg JE; Dehut HA; Hall MK; Schwertfeger KL
J Cell Sci; 2011 Sep; 124(Pt 18):3106-17. PubMed ID: 21868365
[TBL] [Abstract][Full Text] [Related]
11. Amphiregulin mediates progesterone-induced mammary ductal development during puberty.
Aupperlee MD; Leipprandt JR; Bennett JM; Schwartz RC; Haslam SZ
Breast Cancer Res; 2013 May; 15(3):R44. PubMed ID: 23705924
[TBL] [Abstract][Full Text] [Related]
12. Molecular regulators of pubertal mammary gland development.
McNally S; Martin F
Ann Med; 2011 May; 43(3):212-34. PubMed ID: 21417804
[TBL] [Abstract][Full Text] [Related]
13. Null mutation of peroxisome proliferator-activated receptor-interacting protein in mammary glands causes defective mammopoiesis.
Qi C; Kashireddy P; Zhu YT; Rao SM; Zhu YJ
J Biol Chem; 2004 Aug; 279(32):33696-701. PubMed ID: 15161927
[TBL] [Abstract][Full Text] [Related]
14. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad.
Nickerson NK; Mohammad KS; Gilmore JL; Crismore E; Bruzzaniti A; Guise TA; Foley J
PLoS One; 2012; 7(1):e30255. PubMed ID: 22276166
[TBL] [Abstract][Full Text] [Related]
15. Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage.
LaMarca HL; Rosen JM
Breast Cancer Res; 2007; 9(4):304. PubMed ID: 17659070
[TBL] [Abstract][Full Text] [Related]
16. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin.
Yang N; Morrison CD; Liu P; Miecznikowski J; Bshara W; Han S; Zhu Q; Omilian AR; Li X; Zhang J
Cell Cycle; 2012 Aug; 11(15):2922-30. PubMed ID: 22825057
[TBL] [Abstract][Full Text] [Related]
17. Amphiregulin as a novel target for breast cancer therapy.
Willmarth NE; Ethier SP
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):171-9. PubMed ID: 18437539
[TBL] [Abstract][Full Text] [Related]
18. Amphiregulin Is a Critical Downstream Effector of Estrogen Signaling in ERα-Positive Breast Cancer.
Peterson EA; Jenkins EC; Lofgren KA; Chandiramani N; Liu H; Aranda E; Barnett M; Kenny PA
Cancer Res; 2015 Nov; 75(22):4830-8. PubMed ID: 26527289
[TBL] [Abstract][Full Text] [Related]
19. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED
Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449
[TBL] [Abstract][Full Text] [Related]
20. 2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice.
Huh JI; Qiu TH; Chandramouli GV; Charles R; Wiench M; Hager GL; Catena R; Calvo A; LaVallee TM; Desprez PY; Green JE
Endocrinology; 2007 Mar; 148(3):1266-77. PubMed ID: 17158205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
